Uceris FDA Approval History
FDA Approved: Yes (First approved January 14, 2013)
Brand name: Uceris
Generic name: budesonide
Company: Santarus, Inc.
Treatment for: Ulcerative Colitis
Uceris (budesonide) is a glucocorticosteroid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.
Development timeline for Uceris
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.